StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly income taxes payable ($M) [through Q3 2025] ($M)

Annual figures from Eli Lilly's filings and investor materials

Latest, FY2024
1,116
Period ended Dec 31, 2024
Change on a year earlier
–
History
16 years
Since FY2008
Sources
16
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIncome taxes payable ($M) [through Q3 2025] ($M)Year on yearSource
FY2024Dec 31, 20241,116–Form 10-Q (filed 2025-05-01) ↗
FY2022Dec 31, 2022475+274.4%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 2021127-74.4%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 2020495+208.3%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 2019161-59.2%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 2018393-26.2%Form 10-Q (filed 2019-05-02) ↗
FY2017Dec 31, 2017533+347.4%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 2016119-66.8%Form 10-K (filed 2017-02-21) ↗
FY2015Dec 31, 2015359+283.9%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 201493.5-63.2%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 2013254+77.3%Form 10-K (filed 2014-02-19) ↗
FY2012Dec 31, 2012144-45.1%Form 10-K (filed 2013-02-21) ↗
FY2011Dec 31, 2011262-42.8%Form 10-K (filed 2012-02-24) ↗
FY2010Dec 31, 2010458+32.0%Form 10-K (filed 2011-02-22) ↗
FY2009Dec 31, 2009347+51.3%Form 10-K (filed 2010-02-22) ↗
FY2008Dec 31, 2008229–Form 10-Q (filed 2009-07-31) ↗

Cite this data

StockData. (2026). Eli Lilly Income taxes payable ($M) [through Q3 2025] ($M), annual FY2008–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_tax_pay

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.